Terbinafine, Fluconazole, and Itraconazole for Dermatophyte Toenail Onychomycosis
A novel study used network meta-analysis to compare pulse and continuous systemic therapies for toenail onychomycosis.
AAD 2020
VP-102 is Effective Regardless of Number of Baseline Molluscum Contagiosum Lesions
Outcomes of a proprietary topical therapy containing cantharidin for treatment of molluscum contagiosum is not affected by number of baseline lesions.
Biologic Agents Improve Psoriasis Comorbidities Such as Depression and CAD
Biologic agents should be considered for treatment of patients with psoriasis comorbidities including depressive symptoms and coronary artery disease.
Antihistamines, Dupilumab May Improve Hair Growth in Alopecia Areata
Some antihistamines may serve as potential monotherapy or adjunct therapy for alopecia areata.
Topical Minocycline Foam a Promising Option for Treatment of Rosacea
An extension study finds that a novel topical minocycline foam is safe and well tolerated for the treatment of rosacea for up to 52 weeks.
Abrocitinib Consistent, Superior for Treatment of AD in Phase 3 and 2b Trials
Consistent efficacy outcomes of abrocitinib for the treatment of patients with moderate to severe atopic dermatitis were demonstrated in phase 3 and phase 2B studies.
Intranasal Butorphanol Effectively Reduces Pruritus
One of the largest case series of intranasal butorphanol rescue therapy in treating intractable itch demonstrates success.
Spironolactone Not Associated With Recurrence of Breast Cancer
The use of spironolactone for alopecia was not associated with estrogen-dependent cancer recurrence.
Hidradenitis Suppurativa Diagnosis Not Found to Be Associated With Greater Stroke Risk
A diagnosis of hidradenitis suppurativa was not found to be associated with a greater risk for stroke.
Once-Daily Tazarotene Lotion Promising Option for the Treatment of Acne
An evaluation of the safety and efficacy of a novel tazarotene topical for acne finds a possible new treatment option.
- Loading...
Loading...
Loading... 
Loading...